National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Cancer Antigen Market Size, Status and Forecast 2019-2025

Global Cancer Antigen Market Size, Status and Forecast 2019-2025

Goods_sn:yanzewen-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Cancer Antigen Market Size, Status and Forecast 2019-2025

Hard Copy: 3900 USD
PDF Copy (single user): 3900 USD
Multi User License: 5850 USD
Enterprise wide License: 7800 USD
Pages: 90
Tables and Figures: 103
Published Date: Oct. 2019
Publisher: QYR Medical Care Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

Cancer antigens are certain types of proteins secreted into the bloodstream and can be measured in both cancers and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancer cells and other cells of the body which provides information about cancer.
In 2018, the global Cancer Antigen market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Antigen status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Antigen development in United States, Europe and China.

The key players covered in this study
    Thermo Fisher Scientific
    Roche
    Tellgen
    Labor Diagnostika Nord
    Henso Medical (Hangzhou)
    Multisciences (Lianke) Biotech
    Hangzhou AllTest Biotech
    SHINJIN Medics
    Xiamen Baysen Medica Tech

Market segment by Type, the product can be split into
    Cancer Antigen 125
    Cancer Antigen 15-3
    Cancer Antigen 27-29
    Cancer Antigen 19-9
    Others

Market segment by Application, split into
    Hospitals
    Diagnostic Centres
    Ambulatory Surgical Centres
    Others

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Cancer Antigen status, future forecast, growth opportunity, key market and key players.
    To present the Cancer Antigen development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Antigen are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Cancer Antigen Market Size Growth Rate by Type (2014-2025)
        1.4.2 Cancer Antigen 125
        1.4.3 Cancer Antigen 15-3
        1.4.4 Cancer Antigen 27-29
        1.4.5 Cancer Antigen 19-9
        1.4.6 Others
    1.5 Market by Application
        1.5.1 Global Cancer Antigen Market Share by Application (2014-2025)
        1.5.2 Hospitals
        1.5.3 Diagnostic Centres
        1.5.4 Ambulatory Surgical Centres
        1.5.5 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Cancer Antigen Market Size
    2.2 Cancer Antigen Growth Trends by Regions
        2.2.1 Cancer Antigen Market Size by Regions (2014-2025)
        2.2.2 Cancer Antigen Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Cancer Antigen Market Size by Manufacturers
        3.1.1 Global Cancer Antigen Revenue by Manufacturers (2014-2019)
        3.1.2 Global Cancer Antigen Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Cancer Antigen Market Concentration Ratio (CR5 and HHI)
    3.2 Cancer Antigen Key Players Head office and Area Served
    3.3 Key Players Cancer Antigen Product/Solution/Service
    3.4 Date of Enter into Cancer Antigen Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Cancer Antigen Market Size by Type (2014-2019)
    4.2 Global Cancer Antigen Market Size by Application (2014-2019)

5 United States
    5.1 United States Cancer Antigen Market Size (2014-2019)
    5.2 Cancer Antigen Key Players in United States
    5.3 United States Cancer Antigen Market Size by Type
    5.4 United States Cancer Antigen Market Size by Application

6 Europe
    6.1 Europe Cancer Antigen Market Size (2014-2019)
    6.2 Cancer Antigen Key Players in Europe
    6.3 Europe Cancer Antigen Market Size by Type
    6.4 Europe Cancer Antigen Market Size by Application

7 China
    7.1 China Cancer Antigen Market Size (2014-2019)
    7.2 Cancer Antigen Key Players in China
    7.3 China Cancer Antigen Market Size by Type
    7.4 China Cancer Antigen Market Size by Application

8 Japan
    8.1 Japan Cancer Antigen Market Size (2014-2019)
    8.2 Cancer Antigen Key Players in Japan
    8.3 Japan Cancer Antigen Market Size by Type
    8.4 Japan Cancer Antigen Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Cancer Antigen Market Size (2014-2019)
    9.2 Cancer Antigen Key Players in Southeast Asia
    9.3 Southeast Asia Cancer Antigen Market Size by Type
    9.4 Southeast Asia Cancer Antigen Market Size by Application

10 India
    10.1 India Cancer Antigen Market Size (2014-2019)
    10.2 Cancer Antigen Key Players in India
    10.3 India Cancer Antigen Market Size by Type
    10.4 India Cancer Antigen Market Size by Application

11 Central & South America
    11.1 Central & South America Cancer Antigen Market Size (2014-2019)
    11.2 Cancer Antigen Key Players in Central & South America
    11.3 Central & South America Cancer Antigen Market Size by Type
    11.4 Central & South America Cancer Antigen Market Size by Application

12 International Players Profiles
    12.1 Thermo Fisher Scientific
        12.1.1 Thermo Fisher Scientific Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Cancer Antigen Introduction
        12.1.4 Thermo Fisher Scientific Revenue in Cancer Antigen Business (2014-2019)
        12.1.5 Thermo Fisher Scientific Recent Development
    12.2 Roche
        12.2.1 Roche Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Cancer Antigen Introduction
        12.2.4 Roche Revenue in Cancer Antigen Business (2014-2019)
        12.2.5 Roche Recent Development
    12.3 Tellgen
        12.3.1 Tellgen Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Cancer Antigen Introduction
        12.3.4 Tellgen Revenue in Cancer Antigen Business (2014-2019)
        12.3.5 Tellgen Recent Development
    12.4 Labor Diagnostika Nord
        12.4.1 Labor Diagnostika Nord Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Cancer Antigen Introduction
        12.4.4 Labor Diagnostika Nord Revenue in Cancer Antigen Business (2014-2019)
        12.4.5 Labor Diagnostika Nord Recent Development
    12.5 Henso Medical (Hangzhou)
        12.5.1 Henso Medical (Hangzhou) Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Cancer Antigen Introduction
        12.5.4 Henso Medical (Hangzhou) Revenue in Cancer Antigen Business (2014-2019)
        12.5.5 Henso Medical (Hangzhou) Recent Development
    12.6 Multisciences (Lianke) Biotech
        12.6.1 Multisciences (Lianke) Biotech Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Cancer Antigen Introduction
        12.6.4 Multisciences (Lianke) Biotech Revenue in Cancer Antigen Business (2014-2019)
        12.6.5 Multisciences (Lianke) Biotech Recent Development
    12.7 Hangzhou AllTest Biotech
        12.7.1 Hangzhou AllTest Biotech Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Cancer Antigen Introduction
        12.7.4 Hangzhou AllTest Biotech Revenue in Cancer Antigen Business (2014-2019)
        12.7.5 Hangzhou AllTest Biotech Recent Development
    12.8 SHINJIN Medics
        12.8.1 SHINJIN Medics Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Cancer Antigen Introduction
        12.8.4 SHINJIN Medics Revenue in Cancer Antigen Business (2014-2019)
        12.8.5 SHINJIN Medics Recent Development
    12.9 Xiamen Baysen Medica Tech
        12.9.1 Xiamen Baysen Medica Tech Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Cancer Antigen Introduction
        12.9.4 Xiamen Baysen Medica Tech Revenue in Cancer Antigen Business (2014-2019)
        12.9.5 Xiamen Baysen Medica Tech Recent Development

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details


List of Tables and Figures

    Table Cancer Antigen Key Market Segments
    Table Key Players Cancer Antigen Covered
    Table Global Cancer Antigen Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Cancer Antigen Market Size Market Share by Type 2014-2025
    Figure Cancer Antigen 125 Figures
    Table Key Players of Cancer Antigen 125
    Figure Cancer Antigen 15-3 Figures
    Table Key Players of Cancer Antigen 15-3
    Figure Cancer Antigen 27-29 Figures
    Table Key Players of Cancer Antigen 27-29
    Figure Cancer Antigen 19-9 Figures
    Table Key Players of Cancer Antigen 19-9
    Figure Others Figures
    Table Key Players of Others
    Table Global Cancer Antigen Market Size Growth by Application 2014-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Diagnostic Centres Case Studies
    Figure Ambulatory Surgical Centres Case Studies
    Figure Others Case Studies
    Figure Cancer Antigen Report Years Considered
    Table Global Cancer Antigen Market Size 2014-2025 (Million US$)
    Figure Global Cancer Antigen Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Cancer Antigen Market Size by Regions 2014-2025 (Million US$)
    Table Global Cancer Antigen Market Size by Regions 2014-2019 (Million US$)
    Table Global Cancer Antigen Market Share by Regions 2014-2019
    Figure Global Cancer Antigen Market Share by Regions 2014-2019
    Figure Global Cancer Antigen Market Share by Regions 2019
    Table Market Top Trends
    Table Global Cancer Antigen Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Cancer Antigen Market Share by Manufacturers (2014-2019)
    Figure Global Cancer Antigen Market Share by Manufacturers in 2019
    Table Global Cancer Antigen Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Cancer Antigen Product/Solution/Service
    Table Date of Enter into Cancer Antigen Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table Global Cancer Antigen Market Size Share by Type (2014-2019)
    Figure Global Cancer Antigen Market Size Market Share by Type (2014-2019)
    Table Global Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table Global Cancer Antigen Market Size Share by Application (2014-2019)
    Figure Global Cancer Antigen Market Size Market Share by Application (2014-2019)
    Figure Global Cancer Antigen Revenue Market Share by Application in 2018
    Figure United States Cancer Antigen Market Size 2014-2019 (Million US$)
    Table United States Key Players Cancer Antigen Revenue (2018-2019) (Million US$)
    Table United States Key Players Cancer Antigen Market Share (2018-2019)
    Table United States Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table United States Cancer Antigen Market Share by Type (2014-2019)
    Table United States Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table United States Cancer Antigen Market Share by Application (2014-2019)
    Figure Europe Cancer Antigen Market Size 2014-2019 (Million US$)
    Table Europe Key Players Cancer Antigen Revenue (2014-2019) (Million US$)
    Table Europe Key Players Cancer Antigen Market Share (2018-2019)
    Table Europe Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table Europe Cancer Antigen Market Share by Type (2014-2019)
    Table Europe Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table Europe Cancer Antigen Market Share by Application (2014-2019)
    Figure China Cancer Antigen Market Size 2014-2019 (Million US$)
    Table China Key Players Cancer Antigen Revenue (2018-2019) (Million US$)
    Table China Key Players Cancer Antigen Market Share (2018-2019)
    Table China Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table China Cancer Antigen Market Share by Type (2014-2019)
    Table China Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table China Cancer Antigen Market Share by Application (2014-2019)
    Figure Japan Cancer Antigen Market Size 2014-2019 (Million US$)
    Table Japan Key Players Cancer Antigen Revenue (2014-2019) (Million US$)
    Table Japan Key Players Cancer Antigen Market Share (2018-2019)
    Table Japan Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table Japan Cancer Antigen Market Share by Type (2014-2019)
    Table Japan Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table Japan Cancer Antigen Market Share by Application (2014-2019)
    Figure Southeast Asia Cancer Antigen Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Cancer Antigen Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Cancer Antigen Market Share (2018-2019)
    Table Southeast Asia Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Cancer Antigen Market Share by Type (2014-2019)
    Table Southeast Asia Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Cancer Antigen Market Share by Application (2014-2019)
    Figure India Cancer Antigen Market Size 2014-2019 (Million US$)
    Table India Key Players Cancer Antigen Revenue (2018-2019) (Million US$)
    Table India Key Players Cancer Antigen Market Share (2018-2019)
    Table India Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table India Cancer Antigen Market Share by Type (2014-2019)
    Table India Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table India Cancer Antigen Market Share by Application (2014-2019)
    Figure Central & South America Cancer Antigen Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Cancer Antigen Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Cancer Antigen Market Share (2018-2019)
    Table Central & South America Cancer Antigen Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Cancer Antigen Market Share by Type (2014-2019)
    Table Central & South America Cancer Antigen Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Cancer Antigen Market Share by Application (2014-2019)
    Table Thermo Fisher Scientific Company Details
    Table Thermo Fisher Scientific Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Thermo Fisher Scientific Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Thermo Fisher Scientific Recent Development
    Table Roche Company Details
    Table Roche Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Roche Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Roche Recent Development
    Table Tellgen Company Details
    Table Tellgen Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Tellgen Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Tellgen Recent Development
    Table Labor Diagnostika Nord Company Details
    Table Labor Diagnostika Nord Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Labor Diagnostika Nord Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Labor Diagnostika Nord Recent Development
    Table Henso Medical (Hangzhou) Company Details
    Table Henso Medical (Hangzhou) Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Henso Medical (Hangzhou) Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Henso Medical (Hangzhou) Recent Development
    Table Multisciences (Lianke) Biotech Company Details
    Table Multisciences (Lianke) Biotech Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Multisciences (Lianke) Biotech Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Multisciences (Lianke) Biotech Recent Development
    Table Hangzhou AllTest Biotech Company Details
    Table Hangzhou AllTest Biotech Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Hangzhou AllTest Biotech Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Hangzhou AllTest Biotech Recent Development
    Table SHINJIN Medics Company Details
    Table SHINJIN Medics Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure SHINJIN Medics Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table SHINJIN Medics Recent Development
    Table Xiamen Baysen Medica Tech Company Details
    Table Xiamen Baysen Medica Tech Revenue in Cancer Antigen Business (2014-2019) (Million US$)
    Figure Xiamen Baysen Medica Tech Revenue Growth Rate in Cancer Antigen Business (2014-2019)
    Table Xiamen Baysen Medica Tech Recent Development
    Table Global Cancer Antigen Market Size by Regions (Million US$) 2019-2025
    Figure Global Cancer Antigen Market Size Share by Regions (2019-2025)
    Figure Global Cancer Antigen Market Size Share by Regions in 2025
    Figure United States Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Figure China Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Figure India Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Cancer Antigen Market Size Forecast (2019-2025)(Million USD)
    Table Global Cancer Antigen Market Size by Product (2019-2025) (Million US$)
    Figure Global Cancer Antigen Market Size by Product (2019-2025)
    Figure Global Cancer Antigen Market Size by Product in 2025
    Table Global Cancer Antigen Market Size by Application (2019-2025) (Million US$)
    Figure Global Cancer Antigen Market Size by Application (2019-2025)
    Figure Global Cancer Antigen Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.